- Home
- CRL
as of 12-18-2025 3:53pm EST
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
| Founded: | 1947 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 8.0B | IPO Year: | 2000 |
| Target Price: | $191.00 | AVG Volume (30 days): | 794.4K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $91.86 - $200.58 | Next Earning Date: | 11-05-2025 |
| Revenue: | $4,023,704,000 | Revenue Growth: | -0.92% |
| Revenue Growth (this year): | -0.05% | Revenue Growth (next year): | 1.66% |
AI-Powered CRL Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare CRL vs Leading Stocks
See how CRL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CRL Charles River Laboratories International Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.